Child Eye Care Research Gets a Gift of 2 Million Dollar
The American Academy of Ophthalmology received $ 2 million gift from the Knights Templar Eye Foundation (KTEF) to establish a permanent research fund to advance the practice of pediatric ophthalmology.This fund will be used to support the work of researchers investigating both rare and common eye diseases affecting children and to uncover optimal, real-world approaches […]
Intranasal Stimulator Improves Dry Eye Symptoms
A device that zaps nerves inside the nasal cavity can significantly reduce symptoms of dry eye disease, a multifactorial disease that can be difficult to treat, researchers report. The procedure involves a neurostimulator – consisting of a reusable base that produces microcurrents, a disposable tip that inserts in to the nasal cavity, and a battery […]
The IC-8 Lens
Ophthalmic medical device company AcuFocus, Inc. announced yesterday that the first US patient has been implanted with the IC-8 small aperture intraocular lens (IOL) as part of its pivotal study of the IC-8 lens in cataract patients. The company recently announced approval for an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration […]
Getting Ahead With AI Automation
Using the latest technology and algorithms scientists are trying to make every field of study more accurate,and healthcare is not lagging behind. And ophthalmology is one field of health where there are giant strides being made. Read to know more about how artificial intelligence is being used in eye care. For more information: http://retinatoday.com
FDA Approves Dextenza for Treatment of Postoperative Ocular Pain
The US Food and Drug Administration has approved the first intracanalicular insert that delivers dexamethasone (Dextenza, Ocular Therapeutix) to treat ocular pain following ophthalmic surgery, the company has announced. Dextenza, inserted in the lower lacrimal punctum and canaliculus, releases 0.4 mg dexamethasone for up to 30 days following insertion. Dextenza is resorbable and does not […]